Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK

Add to watchlist

183.20

-1.80

(-0.97%)

At close: 05:29PM CET

Loading interactive chart…

Zacks
Apellis (APLS), Sobi Get EU Nod for Rare Blood Disorder Drug
The European Commission approves Apellis (APLS) and Sobi's Aspaveli for the treatment of paroxysmal nocturnal hemoglobinuria in adult patients. Shares rise.
Zacks
Apellis' (APLS) Q3 Loss Widens, Revenues Surpass Estimates
Apellis (APLS) reports wider-than-expected loss for the third quarter of 2021 while revenues surpass expectations.
Zacks
Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline
Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.